Amgen Inc. buy Royal Bank of Canada
Start price
14.06.24
/
50%
€278.00
Target price
14.06.25
€310.92
Performance (%)
5.48%
Price
04.10.24
€291.20
Summary
This prediction is currently active. With a performance of 5.48%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. is trending in the right direction. Dividends of €2.04 are taken into consideration when calculating the performance. This prediction currently runs until 14.06.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 0.438% | 0.438% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $328.00 to $332.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat